CFA
OGN icon

Carroll Financial Associates’s Organon & Co OGN Stock Holding History

Carroll Financial Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$60K Sell
2,015
-156
-7% -$5.08K ﹤0.01% 673
2021
Q3 		$71K Buy
+2,171
New +$69.5K ﹤0.01% 638

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carroll Financial Associates's OGN Position: Q4 2021 in Review

Carroll Financial Associates reduced its Organon & Co (OGN) stake by 7.2% in Q4 2021, selling an estimated $5.08K and leaving 2,015 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #673.

Carroll Financial Associates first reported a position in OGN in Q3 2021 and has held it in 2 quarters since. The position peaked at $71K in Q3 2021. 908 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Carroll Financial Associates held 2,015 shares of Organon & Co worth $60K as of Q4 2021.
  • Carroll Financial Associates sold 156 Organon & Co shares in Q4 2021, an estimated $5.08K.
  • Organon & Co made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #673 holding.
  • Carroll Financial Associates first reported a position in Organon & Co in Q3 2021 and has held it in 2 quarters since.
  • Carroll Financial Associates's Organon & Co position peaked at $71K in Q3 2021.
  • 908 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.